| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Hospital & Healthcare Services
|
Compare with Industry peers |
| Website | http://www.fortismalar.com | |
| Market Cap | 154.73 Cr. | |
| Enterprise Value(EV) | 117.60 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | -8.38 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 67.10 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 29.51 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 2.80 | Calculated using Price: 82.56 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 1.87 Cr. | 18,741,759 Shares |
| FaceValue | 10 | |
| About Fortis Malar Hospitals Ltd. | ||
| Malar Hospitals (an Associate of Fortis Healthcare), like every other Fortis hospital, is a manifestation of the founder's vision of creating a world-class integrated healthcare delivery system in India, entailing the finest medical skills combined with compassionate patient care. | ||
| 1 Day |
|
+5.00% |
| 1 Week |
|
-7.45% |
| 1 Month |
|
+72.72% |
| 3 Month |
|
+41.59% |
| 6 Month |
|
+39.74% |
| 1 Year |
|
+68.28% |
| 2 Year |
|
+41.49% |
| 5 Year |
|
+47.17% |
| 10 Year |
|
+205.21% |
| 9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 8.93 | 6.8 | 3.16 | 3.28 | 1.97 | -8.82 | -8.5 | -9.8 | -21.46 | |
| Return on Capital Employed (%) | 14.17 | 10.96 | 5 | 5.9 | 3.17 | -4.09 | -4.44 | -2.02 | -1.3 | |
| Return on Assets (%) | 6.85 | 4.97 | 2.4 | 2.4 | 1.39 | -5.27 | -4.51 | -5.29 | -10.66 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 91 | 98 | 100 | 103 | 105 | 96 | 89 | 80 | 64 | 59 | |
| Non Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 56 | 47 | 41 | 42 | 38 | |
| Curr. Liab. | 37 | 32 | 30 | 45 | 44 | 36 | 25 | 31 | 32 | 31 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 128 | 130 | 130 | 148 | 149 | 188 | 161 | 152 | 138 | 129 | |
| Non Curr. Assets | 20 | 28 | 33 | 34 | 37 | 126 | 101 | 103 | 54 | 52 | |
| Curr. Assets | 108 | 102 | 97 | 113 | 112 | 62 | 60 | 49 | 84 | 77 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 128 | 130 | 130 | 148 | 149 | 188 | 161 | 152 | 138 | 129 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 118 | 130 | 141 | 149 | 145 | 112 | 69 | 86 | 86 | 74 | |
| Other Income | 8 | 9 | 8 | 8 | 10 | 11 | 8 | 7 | 7 | 7 | |
| Total Income | 126 | 138 | 149 | 158 | 155 | 123 | 78 | 94 | 93 | 81 | |
| Total Expenditure | -110 | -124 | -140 | -147 | -147 | -115 | -76 | -83 | -81 | -75 | |
| PBIDT | 15 | 14 | 9 | 10 | 8 | 8 | 2 | 11 | 11 | 6 | |
| Interest | -1 | 0 | 0 | 0 | -1 | -8 | -7 | -7 | -6 | -5 | |
| Depreciation | -3 | -3 | -4 | -4 | -4 | -13 | -13 | -13 | -12 | -12 | |
| Taxation | -4 | -4 | -1 | -2 | -1 | 3 | 3 | 0 | -8 | -5 | |
| Exceptional Items | -1 | 7 | |||||||||
| PAT | 8 | 6 | 3 | 3 | 2 | -9 | -8 | -8 | -15 | -16 | |
| Minority Interest | |||||||||||
| Share Associate | |||||||||||
| Other Related Items | |||||||||||
| Consolidated Net Profit | 8 | 6 | 3 | 3 | 2 | -9 | -8 | -8 | -15 | -16 | |
| Adjusted EPS | 4 | 3 | 2 | 2 | 1 | -5 | -4 | -4 | -8 | -8 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 5 | 4 | 10 | -9 | 9 | -16 | 0 | -1 | 7 | 6 | |
| Cash Fr. Inv. | -1 | 5 | -22 | 13 | -2 | 6 | 50 | -28 | 8 | 1 | |
| Cash Fr. Finan. | -1 | -1 | -1 | 0 | 0 | -12 | -7 | -10 | -13 | ||
| Net Change | 3 | 10 | -13 | 4 | 7 | -9 | 38 | -36 | 5 | -7 | |
| Cash & Cash Eqvt | 6 | 16 | 3 | 7 | 15 | 5 | 43 | 7 | 12 | 6 |
|
Mon, 22 Apr 2024
PCS Certificate Under Regulation 40(10) Of SEBI Listing Regulations 2015 Please find the enclosed PCS Certificate as per Regulation 40(10) of SEBI LODR Regulations 2015 |
|||||||||||||||||||||
|
Mon, 22 Apr 2024
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A Format of Initial Disclosure to be made by an entity identified as a Large Corporate.
We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No Name of the Company Secretary: Please refer detailed disclosure Designation: Company Secretary EmailId: secretarial.malar@malarhospitals.in Name of the Chief Financial Officer: Yogendra Kumar Kabra Designation: Chief Financial Officer EmailId: secretarial.malar@malarhospitals.in Date: 22/04/2024 Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. |
|||||||||||||||||||||
|
Thu, 18 Apr 2024
Updates on Open Offer (Corrigendum) HSBC Securities and Capital Markets (India) Private Limited HDFC Bank Limited Citigroup Global Markets India Private Limited and Deutsche Equities India Private Limited (Managers to the Open Offer) has submitted to BSE a copy of Corrigendum to the detailed Public Statement dated November 19 2018 with respect to the Open Offer to the Public Shareholders of Fortis Malar Hospitals Ltd ("Target Company"). |
| Thu, 25 Apr 2024 |
High Delivery Percentage
|
Opening at High
|
Closing Above Previous High
|
Closing Above Previous High for 2 Days
|
Making Higher Highs for 2 Days
|
